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aliphatic N,N-dialkylhydrazones†
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Eugenia Marqués-López,a Eleuterio Álvarez,b Rosario Fernández*a and
José M. Lassaletta*b
The enantioselective organocatalytic Strecker-type reaction of aliphatic N,N-dialkylhydrazones is pre-
sented. Using trimethylsilyl cyanide (TMSCN) as the cyanide source, the reaction can be eﬃciently cata-
lyzed by a tert-leucine-derived bifunctional thiourea to aﬀord the corresponding hydrazino nitriles in
good to excellent yields (50–96%) and moderate to good enantioselectivities, up to 86% ee. Further
transformations of the nitrile functionality allow access to useful protected hydrazino acids and imidazol-
idinones. Interestingly, some of the hydrazino nitriles and their derivatives could be recrystallized in high
recovery, yielding essentially pure enantiomers.
Introduction
Hydrazino acids are important bioactive molecules in medic-
inal chemistry (Fig. 1). Some of their derivatives containing the
N–N–C–CvO fragment have been identified as inhibitors of
several amino acid metabolizing enzymes with potential appli-
cations.1 For example, L-Carbidopa is an inhibitor of the
peripheral aromatic L-amino acid decarboxylase (DDC), an
enzyme responsible for the metabolism of levodopa to dopa-
mine, and has improved the eﬃciency of Parkinson’s treat-
ment in combination with L-DOPA.2 Additionally, cyclic
α-hydrazino acids are present in a variety of natural peptides
with remarkable biological properties (antibacterial, anti-
tumour or even anti-HIV therapeutics).3
The L-enantiomer of hexahydropyridazine-3-carboxylic acid
(piperazic acid) also resides within the bicyclic ring system of
many bioactive synthetic products such as cilazapril,4 a drug
widely used in the treatment of hypertension. Furthermore,
α-hydrazino acids have attracted a great deal of interest in
recent years as valuable precursors of conformationally
restricted,5 protease-resistant peptidomimetics.6
Existing routes to enantioenriched hydrazino acids7 rely
generally on elaboration of amino acid derivatives,8 sporadic
catalytic hydrogenation of hydrazones,9 and electrophilic
amination of enolates with azodicarboxylates.10 In this
context, the development of asymmetric catalytic versions of
hydrazone cyanation, which enables direct access to hydrazino
acids, appears to be a very challenging task. In contrast to the
Strecker-type reaction of imines,11 approaches involving cata-
lytic hydrocyanation of hydrazone derivatives have received
relatively little attention. The few inventions reported relied on
N-acylhydrazones as imine surrogates (eqn (1), Scheme 1).12
The first asymmetric variant of the reaction was reported in
2004 by Jacobsen and co-workers employing lanthanide-
PYBOX complexes as the catalysts.12a Recently, the group of
Fig. 1 Hydrazino acids in medicinal chemistry.
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Tsogoeva reported an enantioselective organocatalytic hydra-
zone hydrocyanation by an O-silylated BINOL-phosphate.12b
Considering that the higher basicity of N,N-dialkylhydrazones
over acyl hydrazones oﬀers diﬀerent interaction opportunities
with acidic organocatalysts, we envisioned an alternative pro-
cedure from N,N-dialkylhydrazones (eqn (2), Scheme 1). To the
best of our knowledge, a catalytic reaction for this system has
not been described to date.13 On the other hand, we have
investigated the ambiphilic reactivity of aldehyde N,N-dialkyl-
hydrazones.14 Their imine-type reactivity has been exploited in
Mannich-type additions of ketene silyl acetals and thio-
acetals,15 in Staudinger-like cycloadditions16 and cyanosilyla-
tions13c employing C2-symmetric dialkylamino groups as
chiral auxiliaries. The development of a catalytic system for
this last reaction was problematic for the tendency of nitrogen-
containing reagents to bind acidic metals and undergo side
reactions, decomposition, dimerization or catalyst de-
activation.17 The mild nature of H-bonding and Brønsted acid
organocatalytic activations,18 however, appears to be more
compatible with hydrazones, and applications have been deve-
loped in other contexts.19 We now report on a novel enantio-
selective Strecker-type reaction of N,N-dialkylhydrazones using
bifunctional H-bonding activation.
Results and discussion
We started studies on Strecker-type reactivity employing piper-
idine-containing (1A, R = iBu) or N,N-dibenzyl (1B, R = iBu)
hydrazones and trimethylsilyl cyanide (TMSCN) as model reac-
tions. At room temperature, the non-catalyzed reaction hardly
took place after 72 hours in toluene (<5% conv.) or CHCl3
(<15% conv.), while a polar protic solvent like MeOH aﬀorded
cleanly the corresponding hydrazino nitriles rac-2 in excellent
yields (90–95%) in short reaction times (<4 h),20 suggesting
that HCN, produced in situ, spontaneously adds to the hydra-
zone CvN bond. Preliminary screenings were then performed
to identify the best cyanide source, structure of the N,N-dialkyl-
hydrazone 1, catalyst and solvent for the catalytic enantio-
selective version (Scheme 2, see ESI†).
Several alkaloid-derived quaternary ammonium salts
(bearing a free OH group), (S)-BINOL, (S)-BINOL-derived
phosphoric acid and N,N’-bis[3,5-bis(trifluoromethyl)]phenyl
thiourea (I) were chosen as model organocatalysts for their
ability to establish H-bonding cooperative networks to activate
reagents. Phase transfer catalysts (PTCs) showed a moderate
catalytic activity in Et2O, toluene or CHCl3 (40–50% conv. after
72 hours), but aﬀorded 2 in racemic form, whereas (S)-BINOL
and phosphoric acid derivatives were less active (22–30%
conv., 72 h, racemic). Thiourea I, however, eﬃciently acceler-
ated the model reactions with respect to the background reac-
tion in several solvents (CHCl3: 46–67%, 72 h; CH2Cl2: 58%,
72 h; toluene: 35–47%, 72 h; CH3CN: 72%, 72 h), thereby
opening opportunities for the development of an asymmetric
catalytic version. Aliphatic N,N-dibenzylhydrazones 1B (slightly
superior) and piperidin-1-yl derivatives 1A proved to be better
substrates than other considered N,N-dialkylhydrazones such
as pyrrolidine or N,N-dimethylamino derivatives 1C and 1D,
respectively, while TMSCN provided higher reactivities over
KCN or CH3COCN. Finally, addition of 2–3 equivalents of
PhOH as a protic additive to the reaction mixtures in toluene
improved the catalytic eﬃciency, leading to the desired hydra-
zino nitriles rac-2 in full conversions (>95%) and shorter
reaction times (48 h). Unfortunately, aromatic-substituted
hydrazones showed no reactivity under these conditions.
Previous studies have shown that chiral thiourea-based
catalysts are eﬀective promoters for conducting the activation
of imines towards cyanide attack in highly enantioselective
Strecker-type reactions.21 Hence we performed a screening of
representative thiourea catalysts (Fig. 2) employing the reaction
between (E)-1,1-dibenzyl-2-(3-methylbutylidene)hydrazine
(1au1B, R = i-Bu) and TMSCN–PhOH 3 : 2 in toluene [0.1 M] at
0 °C as the model system and the results are presented in
Table 1.
Initially we explored the behavior of bifunctional catalysts
3a and 3b for the simultaneous activation of the hydrazone (by
the thiourea as a hydrogen-bond donor moiety) and the
cyanide reagent (by the amino nitrogen in 3a or the hydroxyl
group in 3b).22 Unfortunately, the reaction proceeded with low
enantioselectivity after prolonged reaction times (entries 1 and
Scheme 1 Asymmetric catalytic Strecker-type reactions of hydrazones.
Scheme 2 Preliminary optimization of Strecker-type reactions of hydrazones 1
(the best choices are marked in blue).
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2). Bis-thioureas 3c and 3d also aﬀorded product 2a with poor
enantiomeric ratios (entries 3 and 4). Notably, (R)-BINAM
derived bis-thiourea 3d proved to be the most active catalyst,
as a significantly shorter reaction time was observed (from 7
days to 1 day); the enhanced reactivity in this case might be
attributed to the superior acidity associated with the aromatic
groups attached to both N atoms.23 Finally, Jacobsen-type
thiourea catalysts 3e–h were tested (entries 5–6 and 8–9) and
the results revealed 3h as the best catalyst, reaching conver-
sions of around 75% in 3 days (entry 9) and aﬀording 2a with
good enantioselectivity (72% ee). Control experiments con-
ducted without PhOH (entries 7 and 10) revealed the role of
this additive as an activator of TMSCN, aﬀording similar con-
versions in prolonged reaction times (7 days). It is noteworthy
that the catalyst loading could be reduced to 10 mol% without
compromising the selectivity or the reactivity, as shown in
entry 11. A further optimization was then performed to ident-
ify the best solvent, reaction temperature, and protic additives
(see ESI†). From this study, reactions performed in toluene
at 0 °C in the presence of PhOH (2 equivalents) aﬀorded
the best results (>95%, 72% ee). Substitution of PhOH by
diﬀerent alcohols such as iPrOH (>95%, 66% ee), HFIP
(>95%, 64% ee) or 1-naphthol (>95%, 54% ee) PhOH is also
possible, whereas bulkier tBuOH or 2,6-di-tert-butyl-p-cresol
are less eﬃcient, aﬀording 2a in 4 days with 22 and 57% conver-
sion, respectively.‡ These data are in agreement with a nucleo-
philic preactivation of TMSCN to generate HCN;24 the
assistance of the dialkylamino group N atom should not
be ruled out, as related N-acyl hydrazones exhibited no
reactivity.§25
Under the optimized conditions, the reaction was per-
formed on a 0.5 mmol scale for the synthesis of hydrazino
nitrile 2a in 93% yield and matching the same 72% ee (entry
1, Table 2), and the scope of the methodology was explored
with a representative set of aliphatic hydrazones 1b–h. The
results summarized in Table 2 indicate a uniform behaviour
for the synthesis of hydrazino nitriles 2a–h, obtained in good
yields (89–98%) and moderate enantioselectivities (62–86%
ee). As an exception, tert-butyl-substituted hydrazone 1g
required 7 days to aﬀord adduct 2g in 40% yield and 68% ee
(entry 7). This result could be slightly improved by making use
of the superior reactivity observed in trifluorotoluene, 50%
yield and 68% ee in 4 days (entry 8). It is noteworthy that pro-
ducts 2e and 2f proved to be fairly crystalline, and this circum-
stance was exploited to obtain essentially pure enantiomers
(98% ee) after a single crystallization.
Furthermore, the cyano group in adducts 2 can be con-
veniently transformed into a variety of valuable functional
groups. Attempts to hydrolyze directly adducts 2 under acidic
or basic conditions were unsuccessful as a result of a
Fig. 2 Thiourea organocatalysts tested.
Table 1 Screening of catalysts for the enantioselective Strecker-type reaction
of 1aa
Entry Catalyst t (days) Conv.b (%) eec
1 3a 7 48 10
2 3b 7 >95 16
3 3c 7 63 16
4 3d 1 >95 18
5 3e 7 40 40
6 3f 3 71 40
7d 3f 7 76 46
8 3g 3 22 rac
9 3h 3 75 72
10d 3h 7 79 44
11e 3h 3 >95 72
aUnless otherwise stated, reactions were performed with 1a
(0.1 mmol), TMSCN (0.3 mmol), 3 (20 mol%) and PhOH (0.2 mmol) in
toluene (1 mL) at 0 °C. bDetermined by 1H NMR. cDetermined by
HPLC on chiral stationary phases. dWithout PhOH. e 10 mol% catalyst.
‡ Interestingly, reaction performed with bulkier tert-butyl dimethylsilyl cyanide
(TBDMSCN), under optimized conditions, aﬀorded no product after 4 days.
§Reactions performed with acyl hydrazones I–III (0.1 mmol), TMSCN
(0.3 mmol), 3h (10 mol%) and PhOH (0.2 mmol) in toluene (1 mL) aﬀorded no
product after 4 days at rt.
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competing retro-Strecker reaction. Therefore, representative
products 2a,b were transformed into the corresponding
formyl hydrazines 4a,b via a “one-pot” Strecker/formylation¶
sequence in excellent 86 and 98% yield, respectively
(Scheme 3), and these products were selectively hydrolyzed
with concentrated sulfuric acid at 45 °C to aﬀord hydrazino
acids 5a,b in excellent yields. Alternatively, hydrolysis of the
cyano and formyl groups of 4a was performed by sequential
treatment with sulfuric and hydrochloric acid to yield hydra-
zino acid 6a in 60% yield, although with slight racemization.
Unfortunately, attempts to achieve selective removal of the
N-benzyl groups were unsuccessful.
Importantly, single crystallizations made it possible to
improve the enantioselectivities (5a: 82% ee; 5b: >99% ee) while
slightly compromising the chemical yields. Alternatively,
hydrazino nitriles 2a,b were subjected to reduction with
lithium aluminum hydride and subsequent condensation with
triphosgene leading to imidazolidinones 7a,b in good overall
yields and without racemization. These are also valuable pro-
ducts containing an unsymmetrical vicinal diamine moiety,26
often present in biologically active compounds.27
Absolute configuration and stereochemical model
The absolute configuration of acylated derivative (S)-8 (the major
enantiomer isolated by chiral semi-preparative HPLC) was
assigned by X-ray diﬀraction analysis as shown in Scheme 4.28
The absolute configurations of hydrazino nitriles 2 and deriva-
tives 4–7 were assigned by analogy assuming a uniform reac-
tion pathway by which the cyanide attacks from the Re face to
the azomethine CvN bond of hydrazone 1 (Fig. 3).
Jacobsen and co-workers have performed extensive compu-
tational and experimental studies to elucidate the mode of
action of this class of chiral thiourea catalysts in hydrocyana-
tions of imines,29 concluding that the transformation proceeds
via anion-binding catalysis.30 On this basis, a similar mode of
activation is suggested in Fig. 3. In the proposed pathway, an
initial catalyst-promoted hydrazone protonation by HCN is
believed to generate a catalyst-bound hydrazonium–cyanide
ion pair. Collapse of this ion pair and selective C–C bond for-
mation leading to (S) hydrazino nitrile 2 then occur where
the preferred orientation of the hydrazonium cation might
be additionally stabilized by π–π interactions between the
Table 2 Scope of the synthesis of enantioenriched hydrazino nitriles 2a
Entry R t (days) 2 Yieldb (%) eec
1 i-Bu, 1a 3 2a 93 72
2 i-Pr, 1b 3 2b 98 76
3 Et, 1c 3 2c 89 62
4 (CH3)3CH2, 1d 3 2d 93 86
5 CH2Ph, 1e 3 2e 91 82 (98)
6 CH2CH2Ph, 1f 3 2f 96 74 (98)
7 t-Bu, 1g 7 2g 40 68
8d t-Bu, 1g 4 2g 50 68
9 C6H11, 1h 3 2h 90 72
aUnless otherwise stated, reactions were performed with 1 (0.5 mmol),
TMSCN (1.5 mmol), 3 h (10 mol%) and PhOH (1 mmol) in toluene
(5 mL) at 0 °C. b Isolated yield after column chromatography.
cDetermined by HPLC on chiral stationary phases. In parentheses, ee
after a single crystallization. d Reaction performed in trifluorotoluene.
Scheme 4 Synthesis and X-ray structure of (S)-8. H atoms except H8 are
omitted for clarity. Thermal ellipsoids are drawn at 50% probability.
Scheme 3 Synthesis of acids 5 and 6a and imidazolidinones 7.
¶Employing in situ generated acetic formic anhydride under solvent free
conditions. R. Edwards, J. Am. Chem. Soc., 1942, 64, 1583.
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benzhydryl moiety of the optimum catalyst 3h and benzyl
groups of hydrazone 1.k**
Conclusions
In summary, an enantioselective Strecker-type transformation
of aliphatic N,N-dibenzylhydrazones 1 has been developed.
The reaction can be eﬃciently catalyzed by a tert-leucine
derived bifunctional amide–thiourea to aﬀord the corres-
ponding hydrazino nitriles 2 in good to excellent yields
(50–96%) and moderate to good enantioselectivities, up to
86% ee. The protocol requires a combination of TMSCN and
PhOH for the in situ generation of HCN as a cyanide source.
The synthetic potential of adducts 2 has been illustrated by
transformation into protected hydrazino acids 5–6 and imid-
azolidinones 7.
General methods
1H NMR spectra were recorded at 300 MHz or 500 MHz; 13C
NMR spectra were recorded at 75 MHz or 125 MHz, with the
solvent peak used as the internal standard. The following
abbreviations are used to indicate the multiplicity in 1H NMR
spectra: s, singlet; d, doublet; t, triplet; q, quartet; dd, double
doublet; m, multiplet; bs, broad signal. Analytical thin layer
chromatography (TLC) was performed on 0.25 mm silica gel
60-F plates and visualized by ultraviolet irradiation or by
dipping the plates in solutions of Mostain, anisaldehyde
or phosphomolibdic acid stains followed by heating.
Optical rotations were measured using a Perkin-Elmer 341 MC
polarimeter.
Materials
Unless otherwise noted, analytical grade solvents and commer-
cially available reagents, or catalysts, were used without further
purification. For flash chromatography (FC) silica gel
(0.040–0.063 mm) was used. TMSCN was distilled under argon.
Non-commercially available catalysts 3c, d, g, h31 were syn-
thesized according to the literature. Synthesis and characteriz-
ation data of hydrazones 1 are described in the ESI.†
General procedure for the enantioselective addition of TMSCN
to N,N-dibenzylhydrazones 1
TMSCN (0.2 mL, 1.5 mmol, freshly distilled) was added to a
solution of hydrazone 1 (0.5 mmol), catalyst 3h (29 mg,
0.05 mmol) and PhOH (94 mg, 1.0 mmol) in toluene (5 mL) at
0 °C under an argon atmosphere. The mixture was stirred for
3–5 days. The enantiomerically enriched products 2 were puri-
fied by FC (cyclohexane–Et2O, 6 : 1). Enantiomeric excesses
were determined by HPLC analysis.
(S)-2-(2,2-Dibenzylhydrazinyl)-4-methylpentanenitrile (2a).
Colourless oil (93% yield); [α]25D −8.7 (c 1.3, CHCl3) (72% ee);
1H NMR (300 MHz, CDCl3) δ 7.33–7.17 (m, 10H), 3.86 (d, J =
12.9 Hz, 2H), 3.60 (d, J = 12.9 Hz, 2H), 3.33 (t, J = 7.5 Hz, 1H),
2.67 (bs, 1H), 1.57–1.47 (m, 1H), 1.40–1.31 (m, 1H), 1.23–1.13
(m, 1H), 0.65 (d, J = 6.7 Hz, 3H), 0.62 (d, J = 6.6 Hz, 3H);
13C NMR (125 MHz, CDCl3) δ 137.6, 129.7, 128.5, 127.6, 121.4,
61.9, 50.6, 40.7, 24.8, 22.3, 22.1; HRMS (CI): calculated for
[C20H25N3]
+ 307.2048; found: 307.2050. The enantiomeric
excess was determined by HPLC using a Chiralpak AD-H
column [hexane–i-PrOH (98 : 2)]; flow rate 1.0 mL min−1;
τminor = 10.3 min, τmajor = 9.4 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-3-methylbutanenitrile (2b).
Colourless oil (98% yield); [α]25D −14.5 (c 0.9, CHCl3) (76% ee);
1H NMR (500 MHz, CDCl3) δ 7.42–7.29 (m, 10H), 3.96 (d, J =
12.9 Hz, 2H), 3.72 (d, J = 12.9 Hz, 2H), 3.29 (d, J = 5.1 Hz, 1H),
2.80 (bs, 1H), 1.83–1.73 (m, 1H), 0.92 (d, J = 6.7 Hz, 3H), 0.87
(d, J = 6.7 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 137.5, 129.8,
128.4, 127.6, 120.1, 61.6, 58.7, 30.2, 19.3, 18.2; HRMS (CI) calcu-
lated for [C19H23N3]
+ 293.1905; found: 293.1894. The enantio-
meric excess was determined by HPLC using a Chiralpak AD-H
column [hexane–i-PrOH (98 : 2)]; flow rate 1 mL min−1; τminor =
7.7 min, τmajor = 8.2 min.
(S)-2-(2,2-Dibenzylhydrazinyl)butanenitrile (2c). Colourless
oil (89% yield); [α]25D −16.6 (c 0.8, CHCl3) (62% ee); 1H NMR
(300 MHz, CDCl3) δ 7.42–7.27 (m, 10H), 3.93 (d, J = 12.9 Hz,
2H), 3.74 (d, J = 12.9 Hz, 2H), 3.39 (t, J = 6.7 Hz, 1H), 2.82 (s,
1H), 1.66–1.45 (m, 2H), 0.88 (t, J = 7.4 Hz, 3H); 13C NMR
(125 MHz, CDCl3) δ 137.5, 129.8, 128.5, 127.6, 121.0, 61.6,
53.4, 25.1, 10.0; HRMS (CI): calculated for [C18H21N3]
+
279.1735; found: 279.1731. The enantiomeric excess was deter-
mined by HPLC using a Chiralpak AD-H column [hexane–i-
PrOH (98 : 2)]; flow rate 1.0 mL min−1; τminor = 11.6 min,
τmajor = 10.4 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-4,4-dimethylpentanenitrile (2d).
White solid (93% yield); MP: 77–79 °C; [α]25D −23.1 (c 0.3,
CHCl3) (86% ee);
1H NMR (300 MHz, CDCl3) δ 7.44–7.28 (m,
Fig. 3 Activation and stereochemical model.
k In the X-ray structure of compound (S)-8 a π–π stabilizing interaction between
one phenyl ring and the other p-bromo phenyl ring is also observed (see
Scheme 4).
**Supporting this hypothesis, substitution of the N,N-dibenzylamino by the
piperidino group of 1A, (R = i-Bu) resulted in a lower reactivity (70% conversion
after 4 days) and enantioselectivity (20% ee) under the conditions described in
Table 2. No reactivity was observed using 1D.
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10H), 4.00 (d, J = 12.9 Hz, 2H), 3.67 (d, J = 12.9 Hz, 2H), 3.37
(dd, J = 7.9, 4.6 Hz, 1H), 2.73 (s, 1H), 1.66–1.59 (dd, J = 14.0,
7.7 Hz, 1H), 1.28–1.22 (dd, J = 14.0, 5.8 Hz, 1H), 0.78 (s, 9H);
13C NMR (125 MHz, CDCl3) δ 137.7, 129.7, 128.4, 127.6, 122.3,
62.1, 49.2, 45.6, 30.1, 29.5; HRMS (CI): calculated for
[C21H27N3]
+ 321.2205; found: 321.2197. The enantiomeric
excess was determined by HPLC using a Chiralpak AD-H
column [hexane–i-PrOH (99 : 1)]; flow rate 1 mL min−1; τminor =
13.9 min, τmajor = 14.7 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-3-phenylpropanenitrile (2e).
Yellow solid (91% yield); MP: 101–103 °C; [α]25D −31.2 (c 0.5,
CHCl3) (98% ee after a single crystallization from pentane);
1H
NMR (300 MHz, CDCl3) δ 7.32–7.25 (m, 13H), 7.08–7.05 (m,
2H), 3.87 (d, J = 13.0 Hz, 2H), 3.64 (d, J = 13.0 Hz, 2H), 3.62
(overlapped signal, 1H), 2.89 (s, 1H), 2.87–2.72 (m, 2H); 13C
NMR (125 MHz, CDCl3) δ 137.4, 135.4, 129.7, 129.3, 128.9,
128.5, 127.6, 127.5, 120.5, 61.5, 53.2, 37.9; HRMS (CI): calcu-
lated for [C23H23N3]
+ 341.1892; found: 341.1899. The enantio-
meric excess was determined by HPLC using a Chiralpak
OD column [hexane–i-PrOH (98 : 2)]; flow rate 1.0 mL min−1;
τminor = 16.5 min, τmajor = 15.0 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-4-phenylbutanenitrile (2f ).
White solid (96% yield); MP: 65–67 °C; [α]25D −7.2 (c 0.3, CHCl3)
(98% ee after a single crystallization from pentane); 1H NMR
(500 MHz, CDCl3) δ 7.28–7.15 (m, 12H), 7.12–7.09 (m, 1H),
6.94–6.93 (m, 2H), 3.80 (d, J = 12.9 Hz, 2H), 3.64 (d, J =
12.9 Hz, 2H), 3.33 (t, J = 6.9 Hz, 1H), 2.74 (s, 1H), 2.53–2.44 (m,
2H), 1.81–1.74 (m, 1H), 1.71–1.64 (m, 1H); 13C NMR (125 MHz,
CDCl3) δ 140.2, 137.5, 129.8, 128.7, 128.5, 128.4, 127.6, 126.4,
120.8, 61.7, 51.2, 33.3, 31.6; HRMS (CI): calculated for
[C24H25N3]
+ 355.2048; found: 355.2052. The enantiomeric
excess was determined by HPLC using a Chiralpak AD-H
column [hexane–i-PrOH (98 : 2)]; flow rate 1.0 mL min−1; τminor
= 16.8 min, τmajor = 15.0 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-3,3-dimethylbutanenitrile (2g).
Reaction was performed in trifluorotoluene. White solid (50%
yield); MP: 78–80 °C; [α]25D −18.1 (c 1.1, CHCl3) (68% ee);
1H NMR (300 MHz, CDCl3) δ 7.43–7.27 (m, 10H), 4.04 (d, J =
12.9 Hz, 2H), 3.67 (d, J = 12.9 Hz, 2H), 3.19 (s, 1H), 2.81 (s,
1H), 0.88 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 137.6, 129.8,
128.3, 127.5, 120.6, 63.1, 61.5, 34.0, 26.3; HRMS (CI): calcu-
lated for [C20H25N3]
+ 307.2048; found: 307.2040. The enantio-
meric excess was determined by HPLC using a Chiralpak AD-H
column [hexane–i-PrOH (99 : 1)]; flow rate 1.0 mL min−1;
τminor = 7.6 min, τmajor = 8.7 min.
(S)-2-Cyclohexyl-2-(2,2-dibenzylhydrazinyl)acetonitrile (2h).
White solid (90% yield); MP: 63–65 °C; [α]25D −7.8 (c 0.3, CHCl3)
(72% ee); 1H NMR (300 MHz, CDCl3) δ 7.39–7.27 (m, 10H),
3.93 (d, J = 12.9 Hz, 2H), 3.68 (d, J = 12.9 Hz, 2H), 3.27 (d, J =
6.1 Hz, 1H), 1.68–1.58 (m, 4H), 1.48–1.36 (m, 2H), 1.15–0.98
(m, 4H); 13C NMR (75 MHz, CDCl3) δ 137.6, 129.8, 128.4,
127.6, 120.3, 61.5, 57.9, 39.4, 29.7, 28.8, 26.1, 25.8, 25.7; HRMS
(CI): calculated for [C22H27N3]
+ 333.2205; found: 333.2208. The
enantiomeric excess was determined by HPLC using a Chiral-
pak AD-H column [hexane–i-PrOH (98 : 2)]; flow rate 1.0 mL
min−1; τminor = 9.3 min, τmajor = 11.5 min.
General procedure for the one pot Strecker/formylation
protocol
Mixed acetic formic anhydride, prepared from acetic anhy-
dride (1.5 mL) and formic acid (0.6 mL) by heating at 60 °C for
2 hours, was cooled to 0 °C and added to the crude Strecker
reaction described above (on a 0.5 mmol scale). The reaction
mixture was allowed to stir for 1 hour and poured into
ice/water (15 mL) and extracted with dichloromethane
(3 × 10 mL). Combined organic extracts were washed with 10%
aqueous solution of sodium bicarbonate (2 × 10 mL) and brine
(10 mL). The organic extracts were dried over Na2SO4 and the
solvents were removed in vacuo. Flash chromatography (cyclo-
hexane–Et2O, 4 : 1) aﬀorded the corresponding formamide
derivatives 4.
(S)-N’,N’-Dibenzyl-N-(1-cyano-3-methylbutyl)formo-hydrazide
(4a). Colourless oil (86% yield); [α]25D −7.4 (c 1.0, CHCl3) (70%
ee); a mixture of rotamers: 1H NMR (300 MHz, CDCl3) δ 8.26
(s, 0.3H), 8.10 (s, 0.7H), 7.45–7.30 (m, 10H), 4.80 (dd, J = 10.1,
5.5 Hz, 0.7H), 4.52–4.36 (m, 1H), 4.24–3.97 (m, 3H), 3.87 (dd,
J = 10.1, 5.5 Hz, 0.3H), 1.91–1.82 (m, 0.7H), 1.77–1.64 (m,
0.7H), 1.51–1.39 (m, 0.3H), 1.37–1.29 (m, 0.3H), 1.15–1.01 (m,
0.7H), 0.89 (dd, J = 6.6, 1.8 Hz, 5H), 0.72 (d, J = 6.6 Hz, 0.4H),
0.61 (d, J = 6.6 Hz, 0.6H), 0.59–0.49 (m, 0.3H); 13C NMR
(125 MHz, CDCl3) δ 163.8, 161.3, 137.5, 137.4, 135.7, 135.6,
130.1, 129.8, 129.7, 129.5, 129.0, 128.9, 128.8, 128.7, 128.5,
128.4, 128.1, 128.0, 117.1, 60.5, 59.5, 59.2, 57.4, 52.3, 43.9,
41.1, 39.4, 25.2, 24.6, 22.8, 22.7, 21.4, 20.9; HRMS (CI): calcu-
lated for [C21H26N3O]
+ 336.2076; found: 336.2065. The enantio-
meric excess was determined by HPLC using a Chiralpak OD
column [hexane–i-PrOH (98 : 2)]; flow rate 1 mL min−1; τminor =
22.2 min, τmajor = 25.7 min.
(S)-N’,N’-Dibenzyl-N-(1-cyano-2-methylpropyl)formo-hydrazide
(4b). White solid (98% yield); MP: 110–112 °C; [α]25D −13.8
(c 1.0, CHCl3) (76% ee); a mixture of rotamers:
1H NMR
(300 MHz, DMSO, 363 K) δ 8.26 (s, 0.8H), 8.20 (s, 0.2H),
7.51–7.16 (m, 10H), 4.73 (d, J = 9.6 Hz, 0.8H), 4.56–4.29 (m,
0.8H), 4.16–3.95 (m, 3.4H), 2.41–2.24 (m, 0.8H), 1.56–1.42 (m,
0.2H), 1.00 (d, J = 6.7 Hz, 2.3H), 0.86 (d, J = 6.7 Hz, 0.7H), 0.71
(d, J = 6.7 Hz, 2.3H), 0.41 (d, J = 6.7 Hz, 0.7H); 13C NMR
(75 MHz, DMSO, 363 K) δ 165.2, 162.8, 137.6, 137.3, 136.9,
136.2, 129.3, 129.2, 129.0, 128.6, 128.4, 128.3, 128.1, 127.7,
117.6, 117.5, 59.8, 58.3, 58.5, 57.9, 56.6, 49.9, 29.4, 19.3, 18.8,
18.4, 18.1; HRMS (CI): calculated for [C20H24N3O]
+ 322.1919;
found: 322.1915. The enantiomeric excess was determined by
HPLC using a Chiralpak OJ-H column [hexane–i-PrOH (96 : 4)];
flow rate 1 mL min−1; τminor = 25.5 min, τmajor = 35.7 min.
General procedure for the transformation of 4 into acids 5
Sulfuric acid (65% w/v, 17.5 mL) was added to a solution of 4
(0.5 mmol) in the minimal amount of CH2Cl2. The reaction
was stirred at 45 °C for 24 h, followed by pouring into ice/
water and extracted with Et2O (3 × 15 mL). The organic extracts
were dried over Na2SO4 and the solvents were removed
in vacuo. Crystallization from pentane aﬀorded the corres-
ponding acids 5.
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(S)-2-(2,2-Dibenzyl-1-formylhydrazinyl)-4-methylpentanoic acid
(5a). White solid (80% yield); MP: 148–150 °C; [α]25D +55.1
(c 1.0, CHCl3) (82% ee); a mixture of rotamers:
1H NMR
(300 MHz, CDCl3) δ 8.30 (s, 0.1H), 8.04 (s, 0.9H), 7.36–7.25 (m,
10H), 5.24 (s, 1H), 4.47–4.18 (m, 0.4H), 4.12–3.93 (m, 4.6H),
2.41–2.32 (m, 1H), 1.75–1.57 (m, 1H), 1.36–1.26 (m, 1H), 1.04
(d, J = 6.6 Hz, 2.7H), 0.95 (d, J = 6.6 Hz, 2.7H), 0.70 (d, J = 6.6
Hz, 0.3H), 0.63 (d, J = 6.6 Hz, 0.3H); 13C NMR (75 MHz, CDCl3)
δ 174.4, 167.7, 136.1, 129.7, 129.4, 129.2, 128.8, 128.6, 128.3,
128.0, 59.7, 58.6, 58.5, 38.8, 25.6, 23.4, 22.0; HRMS (FAB):
calculated for [C21H26N2NaO3]
+ 377.1841; found: 377.1849. The
enantiomeric excess was determined by HPLC using a Chiral-
pak OJ-H column [hexane–i-PrOH (90 : 10)]; flow rate 1.0 mL
min−1; τminor = 7.2 min, τmajor = 10.2 min.
(S)-2-(2,2-Dibenzyl-1-formylhydrazinyl)-3-methylbutanoic acid
(5b). White solid (66% yield); MP: 118–120 °C; [α]25D +42.7
(c 1.0, CHCl3) (99.8% ee); mixture of rotamers:
1H NMR
(300 MHz, CDCl3) δ 8.23 (s, 1H), 7.43–7.24 (m, 10H), 5.17 (s,
1H), 4.10–3.83 (m, 4H), 3.55 (d, J = 11.5 Hz, 1H), 2.96–2.78 (m,
1H), 1.07 (d, J = 6.6 Hz, 3H), 0.90 (d, J = 6.6 Hz, 3H); 13C NMR
(125 MHz, CDCl3) δ 174.5, 167.5, 136.5, 136.1, 129.3, 129.1,
129.0, 128.9, 128.5, 128.2, 127.9, 69.1, 59.5, 56.9, 27.2, 20.7,
19.7; HRMS (FAB): calculated for [C20H24N2NaO3]
+ 363.1685;
found: 363.1692. The enantiomeric excess was determined by
HPLC using a Chiralpak AD-H column [hexane–i-PrOH
(95 : 5)]; flow rate 1.0 mL min−1; τminor = 30.7 min, τmajor =
26.1 min.
(S)-2-(2,2-Dibenzylhydrazinyl)-4-methylpentanoic acid (6a).
Sulfuric acid (65% w/v, 17.5 mL) was added to a solution of 4a
(168 mg, 0.5 mmol) in the minimal amount of CH2Cl2. The
reaction was stirred at 45 °C for 24 h, followed by pouring into
ice/water and extracted with Et2O (3 × 15 mL). The organic
extracts were removed in vacuo and the crude acid 5a was
treated with 6 M HClaq (15 mL) and stirred at 90 °C for 12 h.
The solvent was removed in vacuo and a solution of crude acid
6a, re-dissolved in CH2Cl2, was treated with NaHCO3 sat. until
pH ∼ 8, and extracted with CH2Cl2 (2 × 10 mL) and Et2O (2 ×
10 mL). The organic extracts were dried over Na2SO4 and the
solvents were removed in vacuo. Crystallization from pentane
aﬀorded the corresponding acid 6a as a white solid (103 mg,
63%); MP: 140–142 °C; [α]25D −3.6 (c 0.5, CHCl3) (62% ee); 1H
NMR (300 MHz, DMSO-d6) δ 7.35–7.21 (m, 10H), 3.83 (d, J =
13.0 Hz, 2H), 3.56 (d, J = 13.0 Hz, 2H), 3.14 (t, J = 6.9 Hz, 1H),
1.51–1.39 (m, 1H), 1.16 (t, J = 6.9 Hz, 2H), 0.71 (d, J = 6.7 Hz,
3H), 0.60 (d, J = 6.7 Hz, 3H); 13C NMR (75 MHz, DMSO-d6)
δ 177.0, 139.3, 129.7, 128.6, 127.4, 61.5, 40.5, 24.6, 23.1, 22.6;
HRMS (CI): calculated for [C20H27N2O2]
+ 327.2073; found:
327.2081. The enantiomeric ratio was determined by HPLC
using a Chiralpak AD-H column [hexane–i-PrOH (95 : 5)]; flow
rate 1.0 mL min−1; τminor = 8.7 min, τmajor = 9.4 min.
General procedure for the transformation of 2 into
imidazolidinones 7
A solution of the Strecker adduct 2 (0.5 mmol) in anhydrous
Et2O (1.0 mL) was added to a suspension of LiALH4 (2.1 mmol,
78 mg) in anhydrous Et2O (10.0 mL) at 0 °C. The reaction
mixture was allowed to warm to room temperature and stirred
overnight. AcOEt (5 mL) and water (0.2 mL) were sequentially
added dropwise to the reaction mixture until a white solid was
formed. The mixture was filtered through Celite and the
solvent was removed in vacuo. The crude amine was taken in
anhydrous CH2Cl2 (4.0 mL), and DIPEA (0.3 mL, 1.5 mmol)
was added dropwise at 0 °C. After 15 minutes, a solution of tri-
phosgene (178 mg, 0.6 mmol) in anhydrous CH2Cl2 (2 mL) was
added dropwise and the reaction mixture was allowed to warm
to room temperature and stirred overnight. The reaction was
diluted with CH2Cl2 (2 mL), washed with water (5 mL), brine
(5 mL), dried over Na2SO4 and the solvent was removed
in vacuo. Flash chromatography (cyclohexane–Et2O, 2 : 1)
aﬀorded the corresponding imidazolidinones 7.
(S)-1-(Dibenzylamino)-5-isobutylimidazolidin-2-one (7a).
White solid (67% yield); MP: 129–131 °C; [α]25D +17.2 (c 0.2,
CHCl3) (70% ee);
1H NMR (500 MHz, CDCl3) δ 7.31–7.16 (m,
10H), 4.33–3.94 (m, 4H), 3.03 (t, J = 7.9 Hz, 1H), 2.80–2.74 (m,
1H), 2.63–2.59 (m, 1H), 1.42–1.37 (m, 1H), 1.26–1.19 (m, 1H),
0.66 (d, J = 6.6 Hz, 3H), 0.58 (d, J = 6.6 Hz, 3H), 0.55–0.49 (m,
1H); 13C NMR (125 MHz, CDCl3) δ 162.0, 138.8, 138.6, 129.7,
128.4, 128.2, 127.3, 61.4, 56.7, 56.3, 44.7, 41.7, 24.5, 23.8, 21.7;
HRMS (CI): calculated for [C21H28N3O]
+ 338.2232; found:
338.2230. The enantiomeric excess was determined by HPLC
using a Chiralpak AD-H column [hexane–i-PrOH (90 : 10)]; flow
rate 1.0 mL min−1; τminor = 5.0 min, τmajor = 4.8 min.
(S)-1-(Dibenzylamino)-5-isopropylimidazolidin-2-one (7b).
White solid (64% yield); MP: 98–100 °C; [α]25D −57.8 (c 0.9,
CHCl3) (76% ee);
1H NMR (300 MHz, CDCl3) δ 7.43–7.32 (m,
10H), 4.58 (d, J = 11.1 Hz, 1H), 4.35 (d, J = 11.1 Hz, 2H), 3.88
(d, J = 11.8 Hz, 1H), 3.43–3.28 (m, 2H), 2.57–2.51 (m, 1H),
2.16–2.06 (m, 1H), 0.73 (d, J = 7.2 Hz, 3H), 0.65 (d, J = 7.2 Hz,
3H); 13C NMR (75 MHz, CDCl3) δ 151.4, 144.8, 137.7, 137.1,
129.8, 129.0, 128.6, 128.1, 127.9, 60.5, 59.6, 55.5, 43.8, 27.4,
18.4, 14.4; HRMS (CI): calculated for [C20H26N3O]
+ 324.2076;
found: 324.2070. The enantiomeric excess was determined by
HPLC using a Chiralpak AD-H column [hexane–i-PrOH
(90 : 10)]; flow rate 1.0 mL min−1; τminor = 5.6 min, τmajor =
5.1 min.
Determination of absolute configuration (Scheme 4): synthesis
of (S)-4-bromo-N-(1-cyano-2-methylpropyl)-N-(1,3-diphenylpropan-
2-yl)benzamide (8)
Et3N (0.7 mL, 5 mmol) and 4-bromobenzoyl chloride (1 g,
5 mmol) were sequentially added to a solution of 2b (150 mg,
0.5 mmol) in anhydrous CH2Cl2 (2.5 mL). The reaction was
stirred at reflux for 48 h, neutralized with a saturated solution
of NaHCO3, and extracted with dichloromethane (3 × 10 mL).
Combined organic extracts were dried over Na2SO4 and the
solvent was removed in vacuo. Flash chromatography (cyclo-
hexane–Et2O, 6 : 1) aﬀorded 8 as a yellow solid (73 mg, 70%,
70% ee). 1H NMR (300 MHz, DMSO 333 K) δ 7.88–7.84 (m,
1H), 7.72–7.67 (m, 1H), 7.51–7.46 (m, 2H), 7.38–7.15 (m, 5H),
7.08–7.03 (m, 2H), 7.00–6.96 (m, 2H), 6.82 (d, J = 7.2 Hz, 2H),
4.73 (d, J = 9.6 Hz, 1H), 4.33 (d, J = 12.5 Hz, 1H), 4.20 (d, J =
12.5 Hz, 1H), 3.83 (d, J = 14.0 Hz, 1H), 3.60 (d, J = 14.0 Hz, 1H),
Organic & Biomolecular Chemistry Paper
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2.67–2.55 (m, 1H), 1.21 (d, J = 6.6 Hz, 3H), 1.06 (d, J = 6.6 Hz,
3H); 13C NMR (125 MHz, DMSO, 333 K) δ 171.6, 167.2, 137.1,
136.0, 135.4, 132.1, 131.7, 130.8, 129.9, 129.8, 129.6, 128.9,
128.3, 127.8, 123.6, 118.8, 59.6, 55.2, 29.6, 20.1, 19.8; HRMS
(CI): calculated for [C26H26BrN3O]
+ 476.1337; found: 476.1340.
The enantioenriched mixture was resolved by semi-preparative
HPLC on a Chiralpak OJ-H column, [hexane–i-PrOH (80 : 20)],
6 mL min−1. Analytical OJ-H, [hexane–i-PrOH (80 : 20)], 1 mL
min−1.
(S)-8: tR = 10.7 min (47 mg, 45%). X-ray quality crystals were
obtained by crystallization in hexane–AcOEt at room temp-
erature. MP: 172–174 °C. [α]25D −14.3 (c 1.0, CHCl3) (99.8% ee).
(R)-8: tR = 21.3 min (10 mg, 11%). [α]
25
D +12.6 (c 0.7, CHCl3)
(99.8% ee).
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